Northern Trust’s Annovis Bio ANVS Stock Holding History

Northern Trust’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127K	Sell	68,070 -73,660	-52%	-$143K	﹤0.01%	4066
2026 Q1	$316K	Buy	141,730 +20,868	+17%	+$57.2K	﹤0.01%	3785
2025 Q4	$418K	Sell	120,862 -198	-0.2%	-$595	﹤0.01%	3721
2025 Q3	$251K	Buy	121,060 +61,546	+103%	+$154K	﹤0.01%	3902
2025 Q2	$129K	Buy	59,514 +18,835	+46%	+$37.2K	﹤0.01%	4053
2025 Q1	$61K	Buy	40,679 +7,899	+24%	+$24.2K	﹤0.01%	4202
2024 Q4	$165K	Buy	32,780 +10,846	+49%	+$78.5K	﹤0.01%	4041
2024 Q3	$177K	Buy	21,934 +2,699	+14%	+$25.3K	﹤0.01%	3917
2024 Q2	$111K	Sell	19,235 -5,032	-21%	-$40.8K	﹤0.01%	4024
2024 Q1	$289K	Sell	24,267 -4,781	-16%	-$52.2K	﹤0.01%	3758
2023 Q4	$543K	Buy	29,048 +18,868	+185%	+$167K	﹤0.01%	3512
2023 Q3	$96.6K	Hold	10,180	–	–	﹤0.01%	4023
2023 Q2	$145K	Buy	+10,180	New	+$144K	﹤0.01%	3937
2021 Q4	–	Sell	-9,098	Closed	-$289K	–	4772
2021 Q3	$289K	Hold	9,098	–	–	﹤0.01%	4002
2021 Q2	$779K	Buy	9,098 +1,673	+23%	+$77.3K	﹤0.01%	3593
2021 Q1	$207K	Buy	+7,425	New	+$159K	﹤0.01%	4106

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust's ANVS Position: Q2 2026 in Review

Northern Trust reduced its Annovis Bio (ANVS) stake by 52% in Q2 2026, selling an estimated $143K and leaving 68,070 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #4066.

Northern Trust first reported a position in ANVS in Q1 2021 and has held it in 16 quarters since. The position peaked at $779K in Q2 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Northern Trust held 68,070 shares of Annovis Bio worth $127K as of Q2 2026.
Northern Trust sold 73,660 Annovis Bio shares in Q2 2026, an estimated $143K.
Annovis Bio made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4066 holding.
Northern Trust first reported a position in Annovis Bio in Q1 2021 and has held it in 16 quarters since.
Northern Trust's Annovis Bio position peaked at $779K in Q2 2021.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.